Literature DB >> 11902591

Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. 1997.

R A Rudick, D E Goodkin, L D Jacobs, D L Cookfair, R M Herndon, J R Richert, A M Salazar, J S Fischer, C V Granger, J H Simon, J J Alam, N A Simonian, M K Campion, D M Bartoszak, D N Bourdette, J Braiman, C M Brownscheidle, M E Coats, S L Cohan, D S Dougherty, R P Kinkel, M K Mass, F E Munschauer, R L Priore, P M Pullicino, B J Scherokman, B Weistock-Guttman, R H Whitham.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11902591

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  2 in total

1.  High concurrent presence of disability in multiple sclerosis. Associations with perceived health.

Authors:  Sverker Johansson; Charlotte Ytterberg; Ingrid M Claesson; Jenny Lindberg; Jan Hillert; Magnus Andersson; Lotta Widén Holmqvist; Lena von Koch
Journal:  J Neurol       Date:  2007-04-02       Impact factor: 4.849

Review 2.  Decoding the complexity of type I interferon to treat persistent viral infections.

Authors:  Elizabeth B Wilson; David G Brooks
Journal:  Trends Microbiol       Date:  2013-11-08       Impact factor: 17.079

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.